Reuters - Generic versions of expensive biotechnology drugs would reduce the amount of money spent on health care in the United States, a Federal Trade Commission report said on Thursday.
Original post by and software by
Jun
9
admin on June 9th, 2009
HealthDay - TUESDAY, June 9 (HealthDay News) -- For most patients with acute
myeloid leukemia (AML) who come out of remission, donor stem cells appear
to offer the best shot at survival, a new analysis shows.
Original post by and software by
AFP - Pharmaceutical giant GlaxoSmithKline has said it had sealed a joint venture with Chinese biotechnology group Shenzhen Neptunus focused on making flu vaccines for China and neighbouring territories.
Original post by and software by
Recent Comments